Indrayani Biotech Ltd
Indrayani Biotech Ltd (INDRANIB) last traded at ₹7.62, a market capitalisation of ₹59.5 crore, on a P/E of 27.5. Over the past 52 weeks the stock has ranged between ₹6.69 and ₹18. Indrayani Biotech Ltd last reported results for the quarter ended Mar 2026, with sales of ₹37.76 crore and net profit of ₹0.98 crore. Figures are as of 25 Aug 2026 and are not real time.
Indrayani Biotech Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Indrayani Biotech Ltd quarterly results
In the quarter ended Mar 2026, sales were ₹37.76 cr, down 25.3% from ₹50.57 cr a year earlier. Net profit turned positive at ₹0.98 cr.
| ₹ crore | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 31.53 | 30.81 | 17.32 | 50.57 | 29.1 | 35.95 | 35.01 | 37.76 |
| Expenses | 25.55 | 25.7 | 14.4 | 56.31 | 26.92 | 33.5 | 32.22 | 35.54 |
| Operating profit | 5.98 | 5.11 | 2.92 | -5.74 | 2.18 | 2.45 | 2.79 | 2.22 |
| OPM % | 18.97% | 16.59% | 16.86% | -11.35% | 7.49% | 6.82% | 7.97% | 5.88% |
| Other income | 0.04 | 0.3 | 0 | 2.78 | 1.06 | 1.8 | 0.83 | 0.88 |
| Interest | 0.83 | 1.42 | 1.03 | 7.07 | 2.17 | 1.89 | 2.47 | 3.08 |
| Depreciation | 4.25 | 2.79 | 1.46 | -1.72 | 0.86 | 1.3 | 1.01 | 1.13 |
| Profit before tax | 0.94 | 1.2 | 0.43 | -8.31 | 0.21 | 1.06 | 0.14 | -1.11 |
| Tax % | 9.57% | -1.67% | 18.60% | 2.53% | 23.81% | 14.15% | 21.43% | -187.39% |
| Net profit | 0.85 | 1.22 | 0.35 | -8.53 | 0.16 | 0.91 | 0.12 | 0.98 |
| EPS (₹) | 0.11 | 0.16 | 0.03 | -1.09 | 0.02 | 0.05 | 0.02 | 0.13 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Indrayani Biotech Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 21 | 61 | 163 | 165 | 130 | 138 |
| Operating profit | -5 | 7 | 17 | 24 | 6 | 10 |
| OPM % | -24% | 11% | 11% | 14% | 4.9% | 7% |
| Net profit | -11 | 4 | 12 | 10 | -6 | 2 |
| EPS (₹) | -1.91 | 0.76 | 1.49 | 0.81 | -0.78 | 0.28 |
TTM is the trailing twelve months to the most recent quarter.
Indrayani Biotech Ltd growth and returns
- 10 Years
- %
- 5 Years
- 46%
- 3 Years
- -5%
- TTM
- 6%
- 10 Years
- %
- 5 Years
- 18%
- 3 Years
- -38%
- TTM
- 135%
- 10 Years
- -1%
- 5 Years
- -13%
- 3 Years
- -49%
- 1 Year
- -42%
- 10 Years
- %
- 5 Years
- 6%
- 3 Years
- 1%
- Last Year
- 3%
Indrayani Biotech Ltd shareholding pattern
Promoters held 32.92% at Jun 2026, broadly unchanged since Jun 2025. DIIs 3.13%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 33.40% | 33.28% | 33.28% | 33.28% | 33.26% | 33.26% | 33.26% | 32.92% |
| DIIs | 5.59% | 5.25% | 3.66% | 3.11% | 3.13% | 3.13% | 3.13% | 3.13% |
| Public | 61.01% | 61.49% | 63.07% | 63.62% | 63.61% | 63.61% | 63.62% | 63.94% |
| No. of shareholders | 24,419 | 25,254 | 25,126 | 25,704 | 25,686 | 25,565 | 25,509 | 25,811 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Indrayani Biotech Ltd corporate filings
- News paper Publication of audited financials results (Standalone & Consolidated) for quarter and year ended March 31, 2026.Company Updatelow impact
Cruxal's analysis: Indrayani Biotech Limited has published its audited standalone and consolidated financial…
Read the full analysis - Audited financial results for quarter and year ended March 31, 2026 along with report of statutory auditors.Company Updatemedium impact
Cruxal's analysis: Indrayani Biotech Limited reported consolidated revenue of 137.83 crore for FY26…
Read the full analysis - Audited Standalone & Consolidated financial results for the quarter and year ended March 31, 2026 along with auditors report.Resulthigh impact
Cruxal's analysis: Indrayani Biotech Limited has released its audited standalone and consolidated financial…
Read the full analysis - Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve Indrayani Biotech Ltd has ....Board Meetinglow impact
Cruxal's analysis: Indrayani Biotech Limited has issued a formal intimation under SEBI Regulation 29…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Indrayani Biotech Ltd
Cruxal reads every Indrayani Biotech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.